We found 2 drugmaker programs for Familial Hypertrophic Cardiomyopathy medicines and 3 charity funds (1 open at our last check). Tell us your insurance below and we'll show what to try first.
Help for Familial Hypertrophic Cardiomyopathy depends mostly on how you're covered. Pick the one that sounds like you. We'll name the funds and programs that fit, and what won't work, so you don't waste a phone call.
Independent foundations pay copays, coinsurance and sometimes insurance premiums for people who already have coverage. Funds open and close as donations come in, so each one shows what the foundation said on the date we checked.
Covers: Out-of-pocket costs for approved medications. Up to $7,200 a year.
Covers: Transportation, meals and lodging to reach an HCMA Center of Excellence. Up to $600 a year.
Covers: Copays, premiums or other treatment costs.
Copay cards lower what people with private insurance pay. Federal rules bar them for Medicare, Medicaid and TRICARE. Free medicine programs are for people without enough coverage and usually have income limits. We read each program on the drugmaker's own site.
Eligible commercially insured patients may pay as little as $10 per 30-day supply; monthly, annual and/or per-claim maximum limits apply. Medicare, Medicaid, TRICARE, VA and other government plans excluded. Patients under 18 must be enrolled by a parent or legal guardian.
Echo Co-Pay: eligible commercially insured patients may pay as little as $0 for required echocardiograms, up to $2,500 per year. Patients under 18 must be enrolled by a parent or legal guardian; not for government insurance or residents of MA, MN or RI. Covers the echo procedure only.
One-time 35-day free trial for first-time patients, regardless of insurance type.
Bridge Program for commercially insured patients: if a coverage decision is delayed 5 days, CAMZYOS is provided at no cost until coverage starts, a prior authorization is denied and not appealed, or 18 dispenses, whichever comes first. Government-insured patients are not eligible.
Patient Access Specialists help you understand prescription insurance coverage and out-of-pocket costs.
The Bristol Myers Squibb Patient Assistance Foundation (800-736-0003) may give CAMZYOS free to eligible US residents within its income limits who have no coverage for it, or who have Medicare and have spent at least 3% of household income on prescriptions this year. People who qualify for Medicare Extra Help are not eligible.
CAMZYOS is now approved for children weighing at least 66 lbs (30 kg) as well as adults, and all MyCAMZYOS programs accept patients under 18 when a parent, legal guardian or other authorized representative enrolls them.
MYQORZO & You Copay Savings Program: eligible commercially insured patients may pay as little as $5 a month for Myqorzo (up to $15,000 a year) and as little as $0 for eligible echocardiograms (up to $2,500 a year). Echocardiogram help is not available in Massachusetts, Minnesota or Rhode Island. Not valid with Medicare, Medicaid, TRICARE, VA, DoD or other government coverage.
MYQORZO & You Bridge Program: eligible commercially insured patients facing an initial insurance denial may receive Myqorzo at no cost for up to 12 months or until coverage is approved, whichever comes first.
MYQORZO & You Free Trial Offer: eligible government-insured patients (excluding DoD, VA and TRICARE) who have never received Myqorzo may get up to a 60-day supply at no cost, a lifetime limit of 2 months.
MYQORZO & You Patient Assistance Program: free Myqorzo for eligible patients who meet financial criteria and have no insurance, have been denied coverage with no appeal options left, or cannot afford their medication. Proof of income and insurance status may be required; enrollment lasts up to the end of the calendar year.
MYQORZO Navigators help with coverage and affordability questions, Monday to Friday, 8 AM to 8 PM ET, at 833-MYQORZO (833-697-6796). A healthcare provider can enroll the patient.
Myqorzo is available only through the Myqorzo REMS program (myqorzorems.com, 1-844-285-7367), so the prescriber and pharmacy must be REMS-certified. Program terms are from the MYQORZO & You terms and conditions PDF linked on myqorzo.com.
Most of these programs start with one call, and having these ready makes it shorter. Tick them off as you go. Nothing here is saved or sent anywhere.
Call the drugmaker's support line first. Its case managers check your benefits and often fill out forms with your doctor. If a charity fund is closed, sign up on the foundation's page to hear when it reopens. Most programs need renewing every year, and many copay cards reset in January.
Yes. Trial Friend lists 2 drugmaker programs for Familial Hypertrophic Cardiomyopathy medicines and 3 charity funds, 1 of them open at our last check. We checked every one at the source on or before October 19, 2026. Which ones fit depends on your insurance. Copay cards are for people with private insurance, charity funds usually need some insurance, and free medicine programs are for people without enough coverage.
No. Federal rules bar drugmaker copay cards for drugs paid by Medicare, Medicaid or TRICARE. For Familial Hypertrophic Cardiomyopathy, 1 charity fund on this page accepts Medicare (1 open at our last check), and 2 drugmaker free medicine programs name Medicare patients among those who may qualify. In 2026, Medicare Part D also caps yearly out-of-pocket costs for covered drugs at $2,100.
At our last check, TotalAssist's Hypertrophic Cardiomyopathy fund was open to new applicants. Funds open and close as donations come in, so check the foundation's page before you apply.
Of the drugmaker programs for Familial Hypertrophic Cardiomyopathy medicines, 2 offer free medicine to people without insurance who qualify, usually with income limits. Most charity funds pay copays and premiums, so they need some insurance. The drugmaker's support line can also check whether you qualify for coverage you don't have yet.
How we check: drugmaker programs come only from each drugmaker's own pages. Fund status is copied from each foundation's list (TotalAssist, Hypertrophic Cardiomyopathy Association, HealthWell Foundation) on the date shown. Programs change, so confirm with the program before you rely on it. Trial Friend shares information, not financial, legal or medical advice, and each program decides who qualifies. See something wrong? Email jason@trialfriend.com.
